Asked by: Jas Athwal (Labour - Ilford South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase standards in and ensure effective regulation of the cosmetic surgery sector.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
On 7 August 2025, the Government announced its plans to introduce measures to improve the safety of the cosmetics sector. This included prioritising the introduction of legal restrictions which will ensure that the highest risk cosmetic procedures are brought into Care Quality Commission regulation and can only be performed by specified regulated healthcare professionals.
In addition, the Government also committed to legislating to introduce a licensing scheme in England for lower risk procedures through powers granted through the Health and Care Act 2022. Under this scheme, which will be operated by local authorities, practitioners will be required to obtain a licence to perform specified cosmetic procedures, and the premises from which they operate will also need to be licensed. To protect children and young people, the Government is also committed to mandating age restrictions for cosmetic procedures.
The proposals will be taken forward through secondary legislation and therefore subject to the parliamentary process before the legal restrictions, or licensing regulations, can be introduced. We are now working with stakeholders to develop detailed plans and intend to consult on proposals for restrictions around the performance of the highest risk procedures in the spring.
Asked by: Connor Rand (Labour - Altrincham and Sale West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to regulate non-surgical aesthetic procedures.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
On 7 August 2025, the Government announced its plans to introduce measures to improve the safety of the cosmetics sector. This included prioritising the introduction of legal restrictions which will ensure that the highest risk cosmetic procedures are brought into Care Quality Commission regulation and can only be performed by specified regulated healthcare professionals.
In addition, the Government also committed to legislating to introduce a licensing scheme in England for lower risk procedures through powers granted through the Health and Care Act 2022. Under this scheme, which will be operated by local authorities, practitioners will be required to obtain a licence to perform specified cosmetic procedures, and the premises from which they operate will also need to be licensed. To protect children and young people, the Government is also committed to mandating age restrictions for cosmetic procedures.
The proposals will be taken forward through secondary legislation and therefore will be subject to the parliamentary process before the legal restrictions, or licensing regulations, can be introduced. We are now working with stakeholders to develop detailed plans and intend to consult on proposals for restrictions around the performance of the highest risk procedures in the spring.
Asked by: Mark Pritchard (Conservative - The Wrekin)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what advice and support his Department is providing to people in Shropshire who claim they have contracted, or might develop, serious illnesses as a result of using Johnson & Johnson talcum powder products.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Individuals in Shropshire who believe they may have been affected by use of talcum products should seek medical advice from their general practitioner. They may also wish to consider contacting specialist organisations for support and information on legal action.
The Medicine and Healthcare products Regulatory Agency (MHRA) is the Government agency responsible for ensuring that medicines and medical devices work and are acceptably safe. Additives in medicines, termed excipients, are required to comply with the standards laid down in pharmacopeial monographs and can only be included in medicinal products at levels that are considered to be safe.
The MHRA is aware of general concerns in relation to the presence of asbestos in commercial talcum powder. However, pharmaceutical grade talcum powder has strict controls on the presence of asbestos. The British Pharmacopeia monograph for Purified Talc states that “Talc derived from deposits that are known to contain associated asbestos is not suitable for pharmaceutical use”. Furthermore, testing is required to confirm the absence of asbestos.
Oversight of commercial talc powder, including advice and support, falls within the remit of the Department for Business and Trade and specifically the Office of Product Safety and Standards (OPSS). The OPSS is the regulator of product safety and seeks to ensure that manufacturers, importers, and all those in the supply chain take steps to ensure that consumer products are safe, and they take any reports of negative health outcomes related to products incredibly seriously. Any serious undesirable effects related to cosmetic products should be directly reported to OPSS, to ensure that they can take the correct action. If a consumer wishes to report a serious undesirable effect, OPSS recommend contacting Trading Standards who can support with the process.
Asked by: Joshua Reynolds (Liberal Democrat - Maidenhead)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of Scotland's proposed regulation of non-surgical cosmetic procedures on England's regulatory framework; and, with reference to his Department's document entitled The licensing of non-surgical cosmetic procedures in England: consultation response, updated on 7 August 2025, what the timeline is for implementing the measures in that document.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
On 7 August 2025, the Government announced its plans to introduce measures to improve the safety of the cosmetics sector. This included prioritising the introduction of legal restrictions which will ensure that the highest risk cosmetic procedures are brought into Care Quality Commission regulation and can only be performed by specified regulated healthcare professionals.
In addition, the Government also committed to legislating to introduce a licensing scheme in England for lower risk procedures through powers granted through the Health and Care Act 2022. Under this scheme, which will be operated by local authorities, practitioners will be required to obtain a licence to perform specified cosmetic procedures, and the premises from which they operate will also need to be licensed. To protect children and young people, the Government is also committed to mandating age restrictions for cosmetic procedures.
The proposals will be taken forward through secondary legislation and therefore will be subject to the parliamentary process before the legal restrictions, or licensing regulations, can be introduced. We are now working with stakeholders to develop detailed plans and intend to consult on proposals for restrictions around the performance of the highest risk procedures in the spring.
We are aware that the Scottish Government is bringing forward its own legislation to introduce measures to protect the public in Scotland from unsafe cosmetic practises. We will continue to work closely with the Scottish Government to foster opportunities for further collaboration and alignment.
Asked by: Joshua Reynolds (Liberal Democrat - Maidenhead)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to his Department's document entitled The licensing of non-surgical cosmetic procedures in England: consultation response, updated on 7 August 2025, what progress has been made on implementing the proposals outlined in that document; and if he will set out the timeline for introducing regulatory measures for non-surgical cosmetic procedures.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
On 7 August 2025, the Government announced its plans to introduce measures to improve the safety of the cosmetics sector. This included prioritising the introduction of legal restrictions which will ensure that the highest risk cosmetic procedures are brought into Care Quality Commission regulation and can only be performed by specified regulated healthcare professionals.
In addition, the Government also committed to legislating to introduce a licensing scheme in England for lower risk procedures through powers granted through the Health and Care Act 2022. Under this scheme, which will be operated by local authorities, practitioners will be required to obtain a licence to perform specified cosmetic procedures, and the premises from which they operate will also need to be licensed. To protect children and young people, the Government is also committed to mandating age restrictions for cosmetic procedures.
The proposals will be taken forward through secondary legislation and therefore will be subject to the parliamentary process before the legal restrictions, or licensing regulations, can be introduced. We are now working with stakeholders to develop detailed plans and intend to consult on proposals for restrictions around the performance of the highest risk procedures in the spring.
We are aware that the Scottish Government is bringing forward its own legislation to introduce measures to protect the public in Scotland from unsafe cosmetic practises. We will continue to work closely with the Scottish Government to foster opportunities for further collaboration and alignment.
Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, who has responsibility for preventing the availability of products containing Melanotan II in England; and what steps he has taken to tackle the availability of these products.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is required to determine whether products are medicines on a case-by-case basis taking into account the definition of a medicine in The Human Medicines Regulations 2012, relevant case law, and any other evidence.
Melanotan II injections and pens are considered medicinal products due to their similarity to an authorised medicinal product and potential application to other medical conditions.
However, tan-enhancing nasal products which are clearly marketed for self-tanning purposes and which do not have a medical purpose do not fall under medicines regulations and are not within the MHRA’s remit.
Medicinal products must hold a relevant Marketing Authorisation to be legally sold and supplied in the United Kingdom. This also guarantees that the medicines have been tested for conformity with strict standards of quality, safety, and efficacy.
Asked by: Olivia Blake (Labour - Sheffield Hallam)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, to set out the legal status of products containing Melanotan II, including i) tan-enhancing injections; ii) tan-enhancing nasal sprays; iii) other products the Department is aware of.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is required to determine whether products are medicines on a case-by-case basis, taking into account the definition of a medicine in the Human Medicines Regulations 2012, relevant case law, and any other evidence.
There are many products which modify physiological function but which are not medicinal products, and case law has established that products that do so while having no beneficial effects on human health cannot be medicines.
Melanotan II injections and pens are considered medicinal products due to their similarity to an authorised medicinal product and potential application to other medical conditions.
However, tan-enhancing nasal products which are clearly marketed for self-tanning purposes and which do not have a medical purpose do not fall under medicines regulations and are not within the MHRA’s remit.
Asked by: Sharon Hodgson (Labour - Washington and Gateshead South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the (a) availability and (b) levels of use of tan-enhancing products containing Melanotan II is being considered in the development of the forthcoming cancer plan.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is taking steps to prevent, diagnose, and treat cancers more quickly, including skin cancers. The forthcoming National Cancer Plan will cover the entirety of the cancer pathway from referral and diagnosis to treatment and ongoing care. It will set out how we will improve outcomes for cancer patients, including by speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately driving up this country’s cancer survival rates. We will publish the National Cancer Plan in the new year to reduce the number of lives lost to cancer over the next 10 years.
We received over 11,000 responses to our call for evidence from individuals, professionals, and organisations, and we are reviewing the submissions from skin cancer partners. While no formal assessment has been made of the availability and levels of use of tan-enhancing products containing Melanotan II, respondents shared concerns about tanning products and their potential links to cancer, particularly melanoma. Our expansive engagement will allow the National Cancer Plan to have patients at its heart.
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the regulation of medicinal products and medical devices in the United Kingdom. Although tanning is not considered to be a medical purpose, injectable products containing Melanotan I or Melanotan II have been determined as medicinal products due to their similarity to the authorised medicine Scenesse.
In relation to nasal sprays containing Melanotan I or Melanotan II, there are no equivalent authorised medicines and in the absence of medicinal claims, they are not regarded as medicinal products.
Medicinal products must hold a relevant Marketing Authorisation to be legally sold and supplied in the UK. This also guarantees that the medicines have been tested for conformity with strict standards of quality, safety, and efficacy.
The MHRA takes action when a medicinal product without appropriate authorisations is identified.
Asked by: Lord Beamish (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to extend the powers for local authorities and their associated enforcement agencies to regulate non-surgical cosmetic procedures and what plans they have to introduce legislation to implement a mandatory licensing scheme in England.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to addressing longstanding concerns around the safety of the cosmetics sector. On 7 August we announced our plans to introduce further regulation in this space.
In the first instance, the Government will prioritise the introduction of legal restrictions to ensure that cosmetic procedures that are deemed to pose the highest level of risk to the public, such as the liquid Brazilian butt lift, are classed as Care Quality Commission (CQC) regulated activities. The new restrictions will mean that these procedures will only be permitted to be performed by suitably qualified regulated healthcare professionals, working for providers who are registered with the CQC. We are working with stakeholders to develop our plans in this space and intend to consult on proposals for restrictions around the performance of the highest risk procedures in spring 2026.
The Government has also committed to legislating to introduce a licensing scheme for non-surgical cosmetic procedures through powers granted through the Health and Care Act 2022. Under this scheme, which will be operated by local authorities, practitioners will be required to obtain a licence to perform specified cosmetic procedures, and the premises from which they operate will also need to be licensed. We are taking forward work to determine which procedures will be included within the local authority licensing scheme and what requirements will have to be met in order to be granted a licence. The proposals will be developed through further stakeholder engagement and public consultation before being taken forward through secondary legislation and the requisite parliamentary processes.
Further details of the Government’s commitments are available in the Government’s response to the 2023 consultation on the GOV.UK website.
Asked by: Lord Beamish (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to introduce a mandated national standard of education and training for those who practise in the aesthetics sector and what plans does the Government have for the implementation of statutory regulation for the sector.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to addressing longstanding concerns around the safety of the cosmetics sector. On 7 August we announced our plans to introduce further regulation in this space.
In the first instance, the Government will prioritise the introduction of legal restrictions to ensure that cosmetic procedures that are deemed to pose the highest level of risk to the public, such as the liquid Brazilian butt lift, are classed as Care Quality Commission (CQC) regulated activities. The new restrictions will mean that these procedures will only be permitted to be performed by suitably qualified regulated healthcare professionals, working for providers who are registered with the CQC. We are working with stakeholders to develop our plans in this space and intend to consult on proposals for restrictions around the performance of the highest risk procedures in spring 2026.
The Government has also committed to legislating to introduce a licensing scheme for non-surgical cosmetic procedures through powers granted through the Health and Care Act 2022. Under this scheme, which will be operated by local authorities, practitioners will be required to obtain a licence to perform specified cosmetic procedures, and the premises from which they operate will also need to be licensed. We are taking forward work to determine which procedures will be included within the local authority licensing scheme and what requirements will have to be met in order to be granted a licence. The proposals will be developed through further stakeholder engagement and public consultation before being taken forward through secondary legislation and the requisite parliamentary processes.
Further details of the Government’s commitments are available in the Government’s response to the 2023 consultation on the GOV.UK website.